![Topotarget skal præs](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Topotarget skal præsentere på 15th Annual Rodman & Renshaw Global Investment Conference
August 30, 2013 08:46 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 08-13 / København, 30. august 2013
Topotarget skal præsentere på 15th Annual Rodman & Renshaw Global Investment Conference, som afholdes i...
![Første patient doser](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Første patient doseret i første del af bekræftende BelCHOP-studie i PTC
August 28, 2013 05:01 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 22-13 / København, 28. august 2013
Topotarget meddeler hermed, at den første patient har fået dosis i studiet til fastsættelse af dosis af belinostat...
![First patient dosed](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
First patient dosed in part one confirmatory BelCHOP study in PTCL
August 28, 2013 05:01 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 22-13 / Copenhagen, August 28, 2013
Topotarget announces that the first patient has been dosed in the dose-finding study of belinostat in...
![Topotarget offentlig](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Topotarget offentliggør delårsrapport 2. kvartal 2013
August 14, 2013 02:27 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 21-13 / København, 14. august 2013
Topotarget meddeler, at bestyrelsen i dag har behandlet og godkendt selskabets delårsrapport for perioden 1....
![Topotarget announces](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Topotarget announces interim report for Q2 2013
August 14, 2013 02:27 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 21-13 / Copenhagen, August 14, 2013
Topotarget announces that the board of directors has reviewed and approved the company’s interim report for the...
![Spectrum Pharmaceuti](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Spectrum Pharmaceuticals announces postponement in filing of NDA for belinostat in PTCL to Q4 2013
August 08, 2013 03:50 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 20-13 / Copenhagen, August 8, 2013
On August 7, 2013, Spectrum Pharmaceuticals announced that the filing of the New Drug Application (NDA) for...
![Spectrum Pharmaceuti](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Spectrum Pharmaceuticals offentliggør udskydelse af indlevering af registreringsansøgning for belinostat i PTCL til 4. kvartal 2013
August 08, 2013 03:50 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 20-13 / København, 8. august 2013
Den 7. august 2013 offentliggjorde Spectrum Pharmaceuticals, at indleveringen af registreringsansøgningen (NDA) for...
![Topotarget announces](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Topotarget announces the time and date for the telephone conference related to the publishing of the interim report for Q2 2013
August 06, 2013 08:38 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 07-13 / Copenhagen, August 6, 2013
Topotarget announces that a teleconference will be held on August 14, 2013 at 1:00 pm CET.
CEO Anders Vadsholt...
![Topotarget offentlig](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Topotarget offentliggør tid og dato for telefonkonference vedr. offentliggørelse af delårsrapport for 2. kvartal 2013
August 06, 2013 08:38 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 07-13 / København, 6. august 2013
Topotarget meddelte i dag, at der vil blive afholdt en telefonkonference den 14. august 2013 kl. 13.00 dansk...
![Belinostat opnår Orp](/news-release/logo/225158/0/225158.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A08&size=2)
Belinostat opnår Orphan Drug-status i Europa for behandlingen af maligne tymomer
July 18, 2013 07:03 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 19-13/ København, 18. juli 2013
Den 17. juli 2013 tildelte Europa-Kommissionen Orphan Drug-status for belinostat til behandling af maligne...